BF Biosciences gains DRAP's approval for brownfield expansion

MG News | September 09, 2024 at 11:49 AM GMT+05:00

Add Mettisglobal as a Trusted Source on Google

0:00

September 09, 2024 (MLN): BF Biosciences Limited, a subsidiary of Ferozsons Laboratories Limited (PSX: FEROZ), has secured approval from the Drug Regulatory Authority of Pakistan (DRAP) for its brownfield expansion (Line II).

This expansion includes a pre-filled syringes line, a liquid and lyophilized line, and a product development section.

The commercial production from the pre-filled syringes line has commenced, whereas the liquid & lyophilized line is under internal validation and will start commercial production in the second quarter of FY 2024-25.

Additionally, BF Biosciences Limited has launched Sematide (Semaglutide) in a pre-filled syringe.

Sematide is the first Glucagon-Like Peptide 1 (GLP1) receptor agonist approved for local manufacture in Pakistan, offering a convenient solution for diabetes management.

The pre-filled syringe eliminates dosing errors and is easy to use by the patients.

Sematide is being manufactured at the new state-of-the-art European prefilled syringes line of BF Biosciences Limited.

Copyright Mettis Link News

Related News

Name	Price/Vol	%Chg/NChg
KSE100	164,467.20 177.74M	0.88% 1428.73
ALLSHR	99,729.91 400.48M	0.85% 842.22
KSE30	48,442.40 98.87M	0.73% 351.39
KMI30	235,633.53 48.82M	0.71% 1656.68
KMIALLSHR	64,521.14 241.88M	0.67% 428.23
BKTi	45,328.82 13.90M	1.11% 496.19
OGTi	33,560.54 2.08M	0.55% 182.19

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	80,835.00	81,360.00 80,635.00	90.00 0.11%
BRENT CRUDE	114.20	116.95 113.35	-1.61 -1.39%
RICHARDS BAY COAL MONTHLY	128.50	0.00 0.00	0.55 0.43%
ROTTERDAM COAL MONTHLY	146.75	146.75 146.75	-0.50 -0.34%
USD RBD PALM OLEIN	1,182.50	1,182.50 1,182.50	0.00 0.00%
CRUDE OIL - WTI	100.16	100.26 99.75	0.26 0.26%
SUGAR #11 WORLD	19.20	19.42 19.03	0.10 0.52%